Ascending Aortic Dilation in BiAV After TAVR

Changes in Ascending Aorta Size After Transcatheter Aortic Valve Replacement in Severe Bicuspid Aortic Stenosis: A Pilot Study With Echocardiographic Follow-up

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03051334

Enrollment

100

Registered

2017-02-13

Start date

2007-01-01

Completion date

2017-12-30

Last updated

2017-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Valve Stenosis

Brief summary

This study sought to evaluate changes in ascending aorta size after transcatheter aortic valve replacement (TAVR) in patients with bicuspid aortic valve (BiAV) compared with patients with tricuspid aortic valve (TAV).

Detailed description

The growth rate of ascending aorta was calculated as annual growth rate using baseline and the last echocardiography. The difference in ascending aorta growth rates between the two groups (BiAV and TAV) were analyzed by independent t-test.

Interventions

OTHERdiagnosed as bicuspid aortic valve

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

21 Years to No maximum

Inclusion criteria

* Severe AS who underwent TAVR

Exclusion criteria

* ascending aorta more than 50mm

Design outcomes

Primary

Measure	Time frame	Description
changes in dimension of ascending aorta	baseline and 1year after TAVR	the annual growth rate of ascending aorta(mm/year) using echocardiography

Countries

South Korea

Contacts

Primary ContactJi-Hyun Jung, MD

jbjhyun@naver.com82-2-2072-0243

Backup ContactHyung-Kwan Kim, MD, PhD

82-2-2072-0243

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026